Tissue Regenix Share Price (TRX)
| Bid price | 12.50 | Open price | 12.75 |
|---|---|---|---|
| Ask price | 13.00 | Prev close | 12.75 |
| High price | 12.93 | Spread | 3.85% |
| Low price | 12.75 | Volume | 334,592 |
Register now for FREE live Tissue Regenix share prices, Tissue Regenix stock quotes, charts, trades and FREE Tissue Regenix company fundamentals, market news and much much more. Why not upgrade to a premium service and get Tissue Regenix Level 2 Data, indepth research tools and investor commentary for Tissue Regenix (TRX) and other London Stock Exchange equities.
Tissue Regenix Share Price Chart
Register now for FREE Tissue Regenix share price charts
Tissue Regenix Share Price Information
| Name | Tissue Regenix | Epic | TRX |
|---|---|---|---|
| Activites | Invests or acquires assets or companies in the technology and science sector as well as to develop businesses in this field | Reuters | TRX.L |
| ISIN | GB00B5SGVL29 | Google Finance | LON:TRX |
| Share Price (p) | 12.75 | Prev. Share Price (p) | 12.75 |
|---|---|---|---|
| Shares in Issue (m) | 653 | Market Cap (£m) | 82 |
| PE Ratio (x) | -7.94 | Div per share (p) | 0.00 |
| Div yield (%) | 0.00 | Div cover (x) | |
| EPS (p) | -1.50 | PEG |
Register now for FREE Tissue Regenix company fundamentals
Tissue Regenix Company News
TRX and NHSBT extend agreement
Tissue Regenix has announces the expansion of its development agreement with existing partner NHS Blood and Transplant (NHSBT). The new agreement will extend the scope of the clinical development activities for Tissue Regenix's decellularised human tissue based devices. A significantly expanded...
Expands scope of development activities with NHSBT
/* */ RNS Number : 0806E Tissue Regenix Group PLC 25 May 2012 TISSUE REGENIX AND NHSBT EXPAND SCOPE OF DEVELOPMENT ACTIVITIES WITH dCELL® TECHNOLOGY YORK, 25 May 2012 - Tissue Regenix, the regenerative medical devices company which uses animal...
Increased losses for Tissue Regenix
Tissue Regenix reveals that increased expenditure on product programmes resulted in an increased loss after tax of £2.7m (2011: £1.7m, excluding deemed cost of reverse acquisition of £3.7m) The company revealed that £25.0m was raised (before expenses) via a share placing completed in December...
More Tissue Regenix Company News >>
Register now for FREE Tissue Regenix company news
Tissue Regenix Share Price Discussions
Tissue Regenix - Delivering regenerative solutions (TRX)
Tissue Regenix is a company that focuses on delivering practical solutions to real clinical issues using its patented dCELL® process. Products The dCELL® Technology comprises a patented process which removes cells and other components from animal and human tissue allowing it to be used...
Torex Retail (TRX)
Following the suspension of the shares on 26th Jan. has anyone any thoughts as to where this company is going?
Register now for FREE Tissue Regenix share price discussions